Stressing that the drug product should only be made available with a prescription from a Registered Medical Practitioner, the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has granted approval to pharmaceutical major Dr. Reddy’s Laboratories to manufacture and market Nimesulide Granules for Oral Suspension 100mg for “Short-term treatment of inflammatory conditions including joint disorders such as rheumatoid arthritis, post-operative painful conditions and fever”.
The approval is subjected to condition that the drug product should be available only under prescription of a Registered Medical Practitioner. Furthermore, the expert panel stated that the prescription should contain clearly displayed Medical Council Registration No. of the Physician.
For more details, check out the link given below: